Living with Advanced Hormone-Receptor Positive Breast Cancer

Ultima Vez Modificado: 28 de octubre del 2013

Share article


English

Dates: Monday, November 18, 2013
Time: 12:00-2:00 PM

Sponsoring Group: Novartis Pharmaceuticals

Location:
Garden Room
2 Albany Street
New Brunswick, NJ 08901

Topics Covered: Metastatic Breast Cancer

Objectives: Educate advanced breast cancer patients and their caregivers on current treatment strategies

Who Should Attend: Advanced Breast Cancer Patients and their Caregivers

Agenda: Cynthia Campbell Baird, OCN, RN will speak on: Understanding a Treatment Option for Postmenopausal Women with Advanced Hormone - Receptor Positive Breast Cancer

Registration Information: RSVP by calling: 1-866-866-9303

Fees: None

Continuing Education: No

Audience: Patients

Miscellaneous: Light lunch will be served. Featured Expert: Cynthia Campbell-Baird, OCN, RN. Also Featured Patient Living with Advanced Breast Cancer

English
News
Hormone Receptor Levels Predict Trastuzumab Effect

Jan 4, 2012 - Patients with human epidermal growth factor receptor 2-positive advanced breast cancer whose tumors also express hormone receptors may be less responsive to the addition of trastuzumab to chemotherapy, suggesting that hormone receptor expression has a predictive role in determining response to therapy, according to research published in the Jan. 1 issue of Cancer.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información